» Articles » PMID: 38828150

Enhanced Optical Imaging and Fluorescent Labeling for Visualizing Drug Molecules Within Living Organisms

Overview
Publisher Elsevier
Specialty Pharmacology
Date 2024 Jun 3
PMID 38828150
Authors
Affiliations
Soon will be listed here.
Abstract

The visualization of drugs in living systems has become key techniques in modern therapeutics. Recent advancements in optical imaging technologies and molecular design strategies have revolutionized drug visualization. At the subcellular level, super-resolution microscopy has allowed exploration of the molecular landscape within individual cells and the cellular response to drugs. Moving beyond subcellular imaging, researchers have integrated multiple modes, like optical near-infrared II imaging, to study the complex spatiotemporal interactions between drugs and their surroundings. By combining these visualization approaches, researchers gain supplementary information on physiological parameters, metabolic activity, and tissue composition, leading to a comprehensive understanding of drug behavior. This review focuses on cutting-edge technologies in drug visualization, particularly fluorescence imaging, and the main types of fluorescent molecules used. Additionally, we discuss current challenges and prospects in targeted drug research, emphasizing the importance of multidisciplinary cooperation in advancing drug visualization. With the integration of advanced imaging technology and molecular design, drug visualization has the potential to redefine our understanding of pharmacology, enabling the analysis of drug micro-dynamics in subcellular environments from new perspectives and deepening pharmacological research to the levels of the cell and organelles.

References
1.
Vargas S, Lin C, Tran Cao H, Ikoma N, AghaAmiri S, Ghosh S . Receptor-Targeted Fluorescence-Guided Surgery With Low Molecular Weight Agents. Front Oncol. 2021; 11:674083. PMC: 8279813. DOI: 10.3389/fonc.2021.674083. View

2.
Maynard J, Lindquist N, Sutherland J, Lesuffleur A, Warrington A, Rodriguez M . Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins. Biotechnol J. 2009; 4(11):1542-58. PMC: 2790208. DOI: 10.1002/biot.200900195. View

3.
Kuriki Y, Yoshioka T, Kamiya M, Komatsu T, Takamaru H, Fujita K . Development of a fluorescent probe library enabling efficient screening of tumour-imaging probes based on discovery of biomarker enzymatic activities. Chem Sci. 2022; 13(16):4474-4481. PMC: 9019911. DOI: 10.1039/d1sc06889j. View

4.
Liang Z, Sun Y, Duan R, Yang R, Qu L, Zhang K . Low Polarity-Triggered Basic Hydrolysis of Coumarin as an AND Logic Gate for Broad-Spectrum Cancer Diagnosis. Anal Chem. 2021; 93(36):12434-12440. DOI: 10.1021/acs.analchem.1c02591. View

5.
Ntziachristos V, Schellenberger E, Ripoll J, Yessayan D, Graves E, Bogdanov Jr A . Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A. 2004; 101(33):12294-9. PMC: 514472. DOI: 10.1073/pnas.0401137101. View